These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate. Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602 [TBL] [Abstract][Full Text] [Related]
6. Development of pseudogout during etanercept treatment. Josefina M; Ana CJ; Ariel V; Silvio AA J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392 [No Abstract] [Full Text] [Related]
7. Digital vasculitis with eosinophilia possibly associated with etanercept therapy. Nakahigashi K; Egawa G; Miyachi Y; Kabashima K Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408 [No Abstract] [Full Text] [Related]
8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [TBL] [Abstract][Full Text] [Related]
9. [TNFalpha inhibitors for the treatment of rheumatoid arthritis]. Sany J; Kaiser MJ Ann Med Interne (Paris); 2002 Feb; 153(1):34-40. PubMed ID: 11994688 [TBL] [Abstract][Full Text] [Related]
10. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Kekow J; Welte T; Kellner U; Pap T Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425 [No Abstract] [Full Text] [Related]
11. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis. Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399 [No Abstract] [Full Text] [Related]
12. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808 [TBL] [Abstract][Full Text] [Related]
13. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis. Michot C; Costes V; Gerard-Dran D; Guillot B; Combes B; Dereure O Br J Dermatol; 2009 Apr; 160(4):889-90. PubMed ID: 19222452 [No Abstract] [Full Text] [Related]
16. [Proper usage of biologics for treatment of rheumatoid arthritis]. Murayama M Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):894-8. PubMed ID: 19469085 [No Abstract] [Full Text] [Related]
17. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Lindsay K; Melsom R; Jacob BK; Mestry N Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195 [No Abstract] [Full Text] [Related]
18. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431 [TBL] [Abstract][Full Text] [Related]
19. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor. Hall HA; Zimmermann B Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649 [No Abstract] [Full Text] [Related]
20. Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al. Bliddal H Arthritis Rheum; 2004 Jun; 50(6):2037-8. PubMed ID: 15188385 [No Abstract] [Full Text] [Related] [Next] [New Search]